ID29198A - Pemakaian uridin 5'-difosfat dan persamaannya untuk mengobati penyakit paru-paru - Google Patents
Pemakaian uridin 5'-difosfat dan persamaannya untuk mengobati penyakit paru-paruInfo
- Publication number
- ID29198A ID29198A IDW991714A ID991714A ID29198A ID 29198 A ID29198 A ID 29198A ID W991714 A IDW991714 A ID W991714A ID 991714 A ID991714 A ID 991714A ID 29198 A ID29198 A ID 29198A
- Authority
- ID
- Indonesia
- Prior art keywords
- difosphate
- uridin
- equation
- lung disease
- treat lung
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5706497P | 1997-08-29 | 1997-08-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
ID29198A true ID29198A (id) | 2001-08-09 |
Family
ID=22008285
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW991714A ID29198A (id) | 1997-08-29 | 1998-08-28 | Pemakaian uridin 5'-difosfat dan persamaannya untuk mengobati penyakit paru-paru |
Country Status (14)
Country | Link |
---|---|
US (3) | US6143279A (fr) |
EP (1) | EP1011688B1 (fr) |
JP (1) | JP2001513568A (fr) |
KR (1) | KR20010023359A (fr) |
CN (1) | CN1268056A (fr) |
AR (1) | AR013454A1 (fr) |
AT (1) | ATE288273T1 (fr) |
AU (1) | AU9124998A (fr) |
BR (1) | BR9811612A (fr) |
CA (1) | CA2300146A1 (fr) |
DE (1) | DE69828892D1 (fr) |
ID (1) | ID29198A (fr) |
WO (1) | WO1999009998A1 (fr) |
ZA (1) | ZA987847B (fr) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6319908B1 (en) | 1996-07-03 | 2001-11-20 | Inspire Pharmaceuticals, Inc. | Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof |
US5763447C1 (en) | 1996-07-23 | 2002-05-07 | Inspire Pharmaceuticals | Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds |
EP1012154B1 (fr) | 1997-07-25 | 2004-03-17 | Inspire Pharmaceuticals, Inc. | Procede de production de masse de di(uridine 5'-tetraphosphate) et de ses sels |
TW593331B (en) | 1997-07-25 | 2004-06-21 | Inspire Pharmaceuticals Inc | Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof |
US6872710B2 (en) * | 1997-07-25 | 2005-03-29 | Inspire Pharmaceuticals, Inc. | Di(uridine 5′)-tetraphosphate and salts thereof |
AU9124998A (en) * | 1997-08-29 | 1999-03-16 | Inspire Pharmaceuticals | Use of uridine 5'-diphosphate and analogs thereof for the treatment of lung iseases |
JP2002533110A (ja) * | 1998-12-23 | 2002-10-08 | ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル | Gタンパク質共役レセプターを使用した目的とする遺伝子の導入 |
AU3612600A (en) * | 1999-02-26 | 2000-09-14 | Inspire Pharmaceuticals, Inc. | Method of promoting mucosal hydration with certain uridine, adenine and cytidine diphosphates and analogs thereof |
AU782966B2 (en) * | 1999-06-08 | 2005-09-15 | University Of Iowa Research Foundation, The | Compounds and methods to enhance RAAV transduction |
US7241447B1 (en) * | 1999-10-07 | 2007-07-10 | University Of Iowa Research Foundation | Adeno-associated virus vectors and uses thereof |
EP1282707A2 (fr) * | 2000-05-11 | 2003-02-12 | Bayer Aktiengesellschaft | Regulation du recepteur humain couple aux proteines g de type p2y |
US6864243B1 (en) | 2000-05-12 | 2005-03-08 | Inspire Pharmaceuticals, Inc. | Method for treating retinal degeneration with purinergic receptor agonists |
US7452870B2 (en) | 2000-08-21 | 2008-11-18 | Inspire Pharmaceuticals, Inc. | Drug-eluting stents coated with P2Y12 receptor antagonist compound |
US7018985B1 (en) | 2000-08-21 | 2006-03-28 | Inspire Pharmaceuticals, Inc. | Composition and method for inhibiting platelet aggregation |
WO2003000056A1 (fr) | 2001-06-25 | 2003-01-03 | Inspire Pharmaceuticals, Inc. | Lubrification d'articulation a l'aide d'agonistes purinergiques de type p2y |
WO2003024980A1 (fr) * | 2001-09-14 | 2003-03-27 | Universite De Liege | Preparation de composes organiques triphosphoryles eventuellement marques au phosphore 32 ou au phosphore 33 |
WO2003028712A2 (fr) * | 2001-09-28 | 2003-04-10 | Universite Libre De Bruxelles | Agonistes de recepteur purinergique et pyrimidinergique pour le traitement de maladies immunitaires mediees par le lymphocyte t cd4+ active |
WO2003039473A2 (fr) * | 2001-11-06 | 2003-05-15 | Inspire Pharmaceuticals, Inc. | Methode de traitement et de prevention de maladies inflammatoires |
US6858615B2 (en) | 2002-02-19 | 2005-02-22 | Parion Sciences, Inc. | Phenyl guanidine sodium channel blockers |
AU2003217863B9 (en) * | 2002-02-28 | 2009-10-29 | Biota Scientific Management Pty Ltd | Nucleotide mimics and their prodrugs |
JP2006505585A (ja) * | 2002-10-18 | 2006-02-16 | モリケム メディシンズ, インコーポレイテッド | ランチビオティクスで眼乾燥症を処置する方法 |
EP1608410A2 (fr) * | 2003-03-31 | 2005-12-28 | University of Iowa Research Foundation | Therapie pharmaco-genique des troubles associes au canal sodique epithelial |
US20090253714A1 (en) * | 2003-08-20 | 2009-10-08 | Johnson Michael R | Methods of reducing risk of infection from pathogens |
US7745442B2 (en) | 2003-08-20 | 2010-06-29 | Parion Sciences, Inc. | Methods of reducing risk of infection from pathogens |
EP1753445A4 (fr) * | 2004-05-06 | 2009-05-20 | Molichem Medicines Inc | Traitement de maladies et de troubles oculaires utilisant des compositions lantibiotiques |
CA2565457A1 (fr) * | 2004-05-06 | 2005-11-17 | Molichem Medicines, Inc. | Traitement de maladies et troubles associes aux membranes au moyen de compositions contenant des lantibiotiques |
GB0417886D0 (en) * | 2004-08-11 | 2004-09-15 | Univ Cardiff | Method and means for enhanced pulmonary delivery |
US7368439B2 (en) * | 2005-06-15 | 2008-05-06 | Bar - Ilan University | Dinucleoside poly(borano)phosphate derivatives and uses thereof |
US7851456B2 (en) * | 2005-06-29 | 2010-12-14 | Inspire Pharmaceuticals, Inc. | P2Y6 receptor agonists for treating lung diseases |
US20070021439A1 (en) * | 2005-07-25 | 2007-01-25 | Parion Sciences, Inc. | Methods of reducing risk of infection from pathogens with soluble amide and ester pyrazinoylguanidine sodium channel blockers |
HUP0600042A3 (en) * | 2006-01-19 | 2012-12-28 | Debreceni Egyetem | New medical use of thiolated pyrimidine-mononucleotides and -nucleosides |
US8618074B2 (en) | 2007-03-15 | 2013-12-31 | Board Of Regents Of The University Of Texas System | GPCR enhanced neuroprotection to treat brain injury |
AR086745A1 (es) | 2011-06-27 | 2014-01-22 | Parion Sciences Inc | 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida |
ES2640485T3 (es) | 2011-08-12 | 2017-11-03 | Universitätsklinikum Freiburg | Uridina y análogos de uridina para el uso en el tratamiento de la enfermedad pulmonar obstructiva crónica |
CN107353316B (zh) | 2011-09-30 | 2020-08-18 | 塔夫斯大学 | 用于治疗神经变性疾病的尿苷二磷酸衍生物、组合物和方法 |
US9833207B2 (en) | 2012-08-08 | 2017-12-05 | William Harrison Zurn | Analysis and clearing module, system and method |
US9913855B2 (en) | 2012-09-28 | 2018-03-13 | Tufts University | Uridine diphosphate derivatives, prodrugs, compositions and uses thereof |
BR112015014349A2 (pt) | 2012-12-17 | 2017-07-11 | Parion Sciences Inc | derivados de cloro-pirazina carboxamida úteis para o tratamento de doenças favorecidas por hidratação mucosa insuficiente |
BR112015014178A2 (pt) | 2012-12-17 | 2017-07-11 | Parion Sciences Inc | compostos de 3,5-diamino-6-cloro-n-(n-(4-fenilbutil)carbamimidoil) pirazina-2- carboxamida |
US9962533B2 (en) | 2013-02-14 | 2018-05-08 | William Harrison Zurn | Module for treatment of medical conditions; system for making module and methods of making module |
US10138265B2 (en) | 2013-03-13 | 2018-11-27 | Tufts University | Uridine nucleoside derivatives, compositions and methods of use |
EP3449925B1 (fr) * | 2013-03-13 | 2021-08-04 | Tufts University | Dérivés de nucléoside d'uridine, compositions et procédés d'utilisation |
JP6694385B2 (ja) | 2013-08-09 | 2020-05-13 | アーデリクス,インコーポレーテッド | リン酸塩輸送阻害のための化合物及び方法 |
US9102633B2 (en) | 2013-12-13 | 2015-08-11 | Parion Sciences, Inc. | Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds |
US9119832B2 (en) | 2014-02-05 | 2015-09-01 | The Regents Of The University Of California | Methods of treating mild brain injury |
WO2017075535A1 (fr) | 2015-10-28 | 2017-05-04 | Oxeia Biopharmaceuticals, Inc. | Méthodes de traitement de troubles neurodégénératifs |
WO2017139381A1 (fr) | 2016-02-08 | 2017-08-17 | University Of Iowa Research Foundation | Procédés pour produire des virus adéno-associés/bocavirus parvovirus chimériques |
CA3016985C (fr) | 2016-03-07 | 2023-07-04 | University Of Iowa Research Foundation | Expression mediee par aav utilisant un promoteur et un activateur synthetiques |
US11142775B2 (en) | 2017-01-13 | 2021-10-12 | University Of Iowa Research Foundation | Bocaparvovirus small noncoding RNA and uses thereof |
KR20210077946A (ko) * | 2019-12-18 | 2021-06-28 | 주식회사 종근당 | 우리딘 5’-디인산(udp), 이의 염 또는 이의 수화물의 제조방법 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL299931A (fr) * | 1962-10-30 | |||
DE2122529A1 (de) * | 1971-05-06 | 1972-12-14 | Max Planck Gesellschaft zur Förde rung der Wissenschaften e V , 3400 Gottin gen | Thiophosphatanaloge der Nucleosid di und tnphosphate sowie Verfahren zu ihrer Herstellung |
JPS5415073B2 (fr) * | 1972-09-14 | 1979-06-12 | ||
US4058601A (en) * | 1974-07-11 | 1977-11-15 | Chugai Seiyaku Kabushiki Kaisha | Method for treating alcoholism |
US4501729A (en) * | 1982-12-13 | 1985-02-26 | Research Corporation | Aerosolized amiloride treatment of retained pulmonary secretions |
DE3709851A1 (de) * | 1987-03-24 | 1988-10-06 | Silica Gel Gmbh Adsorptions Te | Nmr-diagnostische fluessigkeitszusammensetzungen |
GB9027968D0 (en) * | 1990-12-22 | 1991-02-13 | Fisons Plc | Method of treatment |
EP0517573A1 (fr) * | 1991-06-05 | 1992-12-09 | Synthelabo | Compositions pharmaceutiques pour le traitement des affections des voies respiratoires |
US5292498A (en) * | 1991-06-19 | 1994-03-08 | The University Of North Carolina At Chapel Hill | Method of treating lung disease with uridine triphosphates |
US5656256A (en) * | 1994-12-14 | 1997-08-12 | The University Of North Carolina At Chapel Hill | Methods of treating lung disease by an aerosol containing benzamil or phenamil |
US5635160A (en) * | 1995-06-07 | 1997-06-03 | The University Of North Carolina At Chapel Hill | Dinucleotides useful for the treatment of cystic fibrosis and for hydrating mucus secretions |
US5628984A (en) * | 1995-07-31 | 1997-05-13 | University Of North Carolina At Chapel Hill | Method of detecting lung disease |
CN1262556C (zh) * | 1997-02-06 | 2006-07-05 | 印斯拜尔药品股份有限公司 | 特定的二核苷酸和它们作为粘膜纤毛清除和纤毛颤动频率调节剂的应用 |
SE9701219D0 (sv) * | 1997-04-04 | 1997-04-04 | Astra Pharma Prod | New compounds |
AU9124998A (en) * | 1997-08-29 | 1999-03-16 | Inspire Pharmaceuticals | Use of uridine 5'-diphosphate and analogs thereof for the treatment of lung iseases |
-
1998
- 1998-08-28 AU AU91249/98A patent/AU9124998A/en not_active Abandoned
- 1998-08-28 US US09/143,297 patent/US6143279A/en not_active Expired - Lifetime
- 1998-08-28 DE DE69828892T patent/DE69828892D1/de not_active Expired - Lifetime
- 1998-08-28 AT AT98943457T patent/ATE288273T1/de not_active IP Right Cessation
- 1998-08-28 BR BR9811612-6A patent/BR9811612A/pt not_active IP Right Cessation
- 1998-08-28 CN CN98808470A patent/CN1268056A/zh active Pending
- 1998-08-28 EP EP98943457A patent/EP1011688B1/fr not_active Expired - Lifetime
- 1998-08-28 WO PCT/US1998/017894 patent/WO1999009998A1/fr active IP Right Grant
- 1998-08-28 KR KR1020007001997A patent/KR20010023359A/ko not_active Application Discontinuation
- 1998-08-28 JP JP2000507388A patent/JP2001513568A/ja active Pending
- 1998-08-28 AR ARP980104305A patent/AR013454A1/es not_active Application Discontinuation
- 1998-08-28 ZA ZA987847A patent/ZA987847B/xx unknown
- 1998-08-28 CA CA002300146A patent/CA2300146A1/fr not_active Abandoned
- 1998-08-28 ID IDW991714A patent/ID29198A/id unknown
-
1999
- 1999-07-13 US US09/352,390 patent/US6022527A/en not_active Expired - Lifetime
-
2000
- 2000-08-24 US US09/645,161 patent/US6451288B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1011688B1 (fr) | 2005-02-02 |
CN1268056A (zh) | 2000-09-27 |
KR20010023359A (ko) | 2001-03-26 |
US6451288B1 (en) | 2002-09-17 |
AR013454A1 (es) | 2000-12-27 |
JP2001513568A (ja) | 2001-09-04 |
BR9811612A (pt) | 2000-08-08 |
ZA987847B (en) | 1999-06-28 |
DE69828892D1 (de) | 2005-03-10 |
ATE288273T1 (de) | 2005-02-15 |
US6143279A (en) | 2000-11-07 |
CA2300146A1 (fr) | 1999-03-04 |
US6022527A (en) | 2000-02-08 |
EP1011688A1 (fr) | 2000-06-28 |
AU9124998A (en) | 1999-03-16 |
WO1999009998A1 (fr) | 1999-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID29198A (id) | Pemakaian uridin 5'-difosfat dan persamaannya untuk mengobati penyakit paru-paru | |
CY2018020I1 (el) | Θεραπεια της νοσου ρομρε | |
ID25504A (id) | Pencegahan dan pengobatan penyakit amiloidogenik | |
ID26540A (id) | Penggunaan campuran mikropigmen untuk mencegah pencoklatan dan untuk memperterang kulit dan rambut | |
ID21859A (id) | Bahan lembaran serupa-kulit dan metode untuk memproduksi bahan tersebut | |
DE69505657D1 (de) | Fluorcarbonetherhybriden enthaltende physiologich akzeptabele emulsionen und verwendungsverfahren | |
ID26725A (id) | Zat untuk mencegah dan mengobati penyakit-penyakit kulit | |
DE69117117D1 (de) | Reinigungszusammensetzung zur Vorbeugung und Milderung von Hautreizungen | |
NO981388L (no) | Bedring av Dupuytrens sykdom | |
IT240192Y1 (it) | Apparecchiatura per l'esfoliazione dello stato corneo dell'epidermidee la rivitalizzazione della pelle | |
NO953262D0 (no) | Bedring av Dupuytrens sykdom | |
FI990171A (fi) | Uusia yhdisteitä ja koostumuksia tryptaasiaktiivisuuden liittyvien tautien hoitamiseksi | |
FI965204A (fi) | Bromelaiinin lääkekäyttö | |
ID20819A (id) | Semaforin l manusia (h-sema l) dan semaforin yang sesuai dalam spesies lainnya | |
ID27576A (id) | Penggunaan siklosporin dalam pengobatan penyakit-penyakit peradangan autoimun | |
TR199701051A3 (tr) | 2' -Fluoro-5-metil- -l-arabino-furanosilüridin hazirlanma prosesi | |
ID21847A (id) | Komposisi insektisida dan metoda penggunaannya | |
ID18913A (id) | Turunan turunan tienopiridin dan penggunaannya | |
ID22378A (id) | Komposisi untuk mencegah dan mengobati penyakit gusi | |
GB9708067D0 (en) | Rapid and long lasting biocidal system and its use to the treatment of hard surfaces | |
FI963263A (fi) | Bromelaiinin lääkinnällinen käyttö | |
DE69710305D1 (de) | Derivate von 4-Vinyl-4'-alpha-hydroxyethyl-biphenyl | |
FI973392A (fi) | Fluorihiilinesteiden käyttö kiihdyttämään keuhko- ja muiden kudosten kasvua | |
AU8799398A (en) | Physiological combination of active substances to enhance the skin's defenses against noxious agents | |
UA25492A (uk) | Спосіб лікуваhhя хвороби гіршпруhга |